A detailed history of First Community Trust Na transactions in Abb Vie Inc. stock. As of the latest transaction made, First Community Trust Na holds 11,808 shares of ABBV stock, worth $2.14 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
11,808
Previous 11,852 0.37%
Holding current value
$2.14 Million
Previous $2.03 Million 14.71%
% of portfolio
1.92%
Previous 1.74%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$163.84 - $199.33 $7,208 - $8,770
-44 Reduced 0.37%
11,808 $2.33 Million
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $2,397 - $2,731
-15 Reduced 0.13%
11,852 $2.16 Million
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $110,080 - $123,976
-800 Reduced 6.32%
11,867 $1.84 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $4,007 - $4,639
-30 Reduced 0.24%
12,667 $1.89 Million
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $530 - $659
-4 Reduced 0.03%
12,697 $1.71 Million
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $13,014 - $14,988
-90 Reduced 0.7%
12,701 $2.02 Million
Q4 2022

Jan 10, 2023

BUY
$138.31 - $165.87 $39,971 - $47,936
289 Added 2.31%
12,791 $2.07 Million
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $74,218 - $85,123
-553 Reduced 4.24%
12,502 $1.68 Million
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $13,211 - $16,796
-96 Reduced 0.73%
13,055 $2 Million
Q1 2022

Apr 06, 2022

BUY
$131.98 - $163.75 $32,467 - $40,282
246 Added 1.91%
13,151 $2.13 Million
Q4 2021

Feb 16, 2022

BUY
$107.43 - $135.93 $1.39 Million - $1.75 Million
12,905 New
12,905 $1.75 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Community Trust Na Portfolio

Follow First Community Trust Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Community Trust Na, based on Form 13F filings with the SEC.

News

Stay updated on First Community Trust Na with notifications on news.